STAGLIANO NANCY enters PANDION THERAPEUTICS, INC. with 58.06K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Indirect Derivatives
Filed: 7/16/2020ACC: 0000899243-20-019452
Director
Since Jul 2020
58.06K
Baseline shares
0.00
Direct ownership
0 positions
15K
Derivative underlying
2 instruments
1
Security positions
58.06K indirect
Non-Derivative Holdings1
Common Stock
IndirectShares owned58.06K
Total
58.06K indirect58.06K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 58.06K | Indirect |
| Total | 58.06K | 58.06K indirect |
Derivative Holdings2
Series B Preferred Stock
IndirectUnderlying security
Common Stock
Underlying shares
9.39K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Series A Preferred Stock
IndirectUnderlying security
Common Stock
Underlying shares
5.61K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
15K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Series B Preferred Stock Indirect | Common Stock | — | — | 9.39K | N/A | |
| Series A Preferred Stock Indirect | Common Stock | — | — | 5.61K | N/A | |
| Total | 15K | 0.00 | ||||